{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T19:36:04Z","timestamp":1790105764098,"version":"4.0.1"},"reference-count":79,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Heterotopic ossification (HO) involves the ectopic deposition of bone in soft tissues, frequently occurring as a complication post-hip trauma or surgery. To prevent HO following total hip arthroplasty (THA), irradiation has been extensively employed, alongside the use of nonsteroidal anti-inflammatory drugs (NSAIDs). Given the extensive range of NSAIDs available, determining the most effective NSAID or irradiation protocol for prophylaxis continues to be a matter of debate.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Adhering to the PRISMA guidelines, a comprehensive search was conducted across PubMed, Embase, Cochrane Library, and Web of Science to identify relevant randomized controlled trials. To minimize bias in literature evaluation, two authors independently searched and assessed the articles. In cases of disagreement, a third author was consulted. We strictly implement the inclusion and exclusion criteria. Using the criteria for assessing bias in the Cochrane Collaboration Network, two writers independently evaluated the quality of the included studies. We systematically extracted and assessed data according to the level of evidence presented in the articles. A Bayesian network meta-analysis (NMA) was implemented to evaluate and contrast the efficacy of irradiation and six distinct NSAIDs in preventing HO after THA. The results were computed using the GEMTC package in R (V.4.4.1). The consistency of the model was tested using nodal analysis. The priority of drug efficacy was comprehensively evaluated using rank probability and the surface under the cumulative ranking curve (SUCRA). Stata 16 was used to assess publication bias, and sensitivity analysis was performed using the one-by-one elimination method. The protocol for this study was officially registered with the International Platform of Registered Systematic Review and Meta-analysis Protocols (INPLASY).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 461 studies were identified, and 17 studies were finally included in the analysis. The meta-analysis incorporated data from 3,014 patients: 629 administered ibuprofen, 54 with naproxen, 117 receiving celecoxib, 426 on indomethacin, 295 treated with diclofenac, 45 on etoricoxib, 522 subjected to irradiation, and 926 serving as controls. These trials reported an average age ranging from 59 to 75\u00a0years, with males comprising 31.2%\u201363% of subjects. The total incidence rate of HO in all control groups was 55.2%. In terms of effectiveness, compared with the control, four strategies showed a low incidence of HO, including naproxen (OR = 0.08, 95% CrI 0.01\u20130.60), indomethacin (OR = 0.13, 95% CrI 0.04\u20130.41), diclofenac (OR = 0.06, 95% CrI 0.01\u20130.29), and irradiation (OR = 0.08, 95% CrI 0.02\u20130.3). Diclofenac was more beneficial than ibuprofen (OR = 0.10, 95% CrI 0.01\u20130.97). The probabilities derived from the surface under the cumulative ranking curve (SUCRA) algorithm are as follows: Diclofenac (78.0%), etoricoxib (71.6%), irradiation (67.3%), naproxen (66.7%), indomethacin (53.2%), celecoxib (38.8%), ibuprofen (18.6%), and a control group (6.8%). Because stronger evidence supports the efficacy of diclofenac. The most likely ranking for the effectiveness of preventing HO after THA is as follows: Diclofenac &amp;gt; etoricoxib &amp;gt; irradiation &amp;gt; naproxen &amp;gt; indomethacin &amp;gt; celecoxib &amp;gt; ibuprofen.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In terms of preventive efficacy, diclofenac and etoricoxib demonstrated the most favorable performance in preventing HO after THA within this network meta-analysis. Irradiation, naproxen, and indomethacin are also satisfactory options, while ibuprofen is ineffective. Given the advantages shown by etoricoxib and celecoxib, further randomized controlled trials are recommended to clarify their effects. Our conclusions require confirmation through additional high-quality studies.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fphar.2025.1601349","type":"journal-article","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T10:01:02Z","timestamp":1747821662000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Effectiveness and priority of irradiation and six NSAIDs in prevention heterotopic ossification after total hip arthroplasty: a network meta-analysis of randomized controlled studies"],"prefix":"10.3389","volume":"16","author":[{"given":"Fei","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changshun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuwei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongqin","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qifan","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3109\/17453679408995421","article-title":"Short-term ibuprofen to prevent ossification after hip arthroplasty. No effects in a prospective randomized study of 47 arthrosis cases","volume":"65","author":"Ahrengart","year":"1994","journal-title":"Acta Orthop. Scand."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.arth.2016.11.030","article-title":"Heterotopic ossification in primary total hip arthroplasty using the direct anterior vs direct lateral approach","volume":"32","author":"Alijanipour","year":"2017","journal-title":"J. Arthroplasty"},{"key":"B3","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jor.2025.03.037","article-title":"Postoperative complications rates and outcomes following total hip arthroplasty in patients with ankylosing spondylitis: a systematic review","volume":"69","author":"Anaspure","year":"2025","journal-title":"J. Orthop."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s00590-022-03244-9","article-title":"Heterotopic ossification in primary total hip arthroplasty: risk factor analysis","volume":"33","author":"Aprato","year":"2023","journal-title":"Eur. J. Orthop. Surg. Traumatol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.ijrobp.2006.03.053","article-title":"Heterotopic ossification: pathophysiology, clinical features, and the role of radiotherapy for prophylaxis","volume":"65","author":"Balboni","year":"2006","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"B6","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s10195-012-0180-4","article-title":"Adherence to routine use of pharmacological prophylaxis of heterotopic ossification after total hip arthroplasty: results from an Italian multicenter, prospective, observational survey","volume":"13","author":"Barbato","year":"2012","journal-title":"J. Italian Soc. Orthop. Traumatol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1177\/0363546511434285","article-title":"The incidence of heterotopic ossification after hip arthroscopy","volume":"40","author":"Bedi","year":"2012","journal-title":"Am. J. sports Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1055\/s-2008-1039411","article-title":"Indomethacin-short-term-therapy vs. single-low-dose-radiatio for prophylaxis of periarticular ossifications (PAO) following total hip arthroplasty","volume":"135","author":"Bremen-Kuhne","year":"1997","journal-title":"Z. fur Orthopadie ihre Grenzgeb."},{"key":"B9","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s00264-013-1781-0","article-title":"Is etoricoxib effective in preventing heterotopic ossification after primary total hip arthroplasty?","volume":"37","author":"Brunnekreef","year":"2013","journal-title":"Int. Orthop."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.2106\/00004623-200112000-00003","article-title":"Indomethacin compared with localized irradiation for the prevention of heterotopic ossification following surgical treatment of acetabular fractures","author":"Burd","year":"2001","journal-title":"J. Bone Jt. Surg. Am."},{"key":"B11","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.ijsu.2018.12.011","article-title":"Optimal strategies for the prevention of heterotopic ossification after total hip arthroplasty: a network meta-analysis","volume":"62","author":"Cai","year":"2019","journal-title":"Int. J. Surg."},{"key":"B12","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3109\/17453679809117607","article-title":"Indomethacin for prevention of heterotopic ossification after hip arthroplasty. A randomized comparison between 4 and 8 days of treatment","volume":"69","author":"Dorn","year":"1998","journal-title":"Acta Orthop. Scand."},{"key":"B13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3109\/17453678508992973","article-title":"Effect of ibuprofen on heterotopic ossification after hip replacement","volume":"56","author":"Elmstedt","year":"1985","journal-title":"Acta Orthop. Scand."},{"key":"B14","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1023\/a:1024830213832","article-title":"Prevention of heterotopic ossification after total hip replacement with NSAIDs","volume":"25","author":"Fijn","year":"2003","journal-title":"Pharm. World Sci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1136\/bmj.38925.471146.4F","article-title":"Safety and efficacy of routine postoperative ibuprofen for pain and disability related to ectopic bone formation after hip replacement surgery (HIPAID): randomised controlled trial","volume":"333","author":"Fransen","year":"2006","journal-title":"Br. Med. J."},{"key":"B16","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3109\/17453679108993597","article-title":"Naproxen prevention of heterotopic ossification after hip arthroplasty. A prospective control study of 55 patients","volume":"62","author":"Gebuhr","year":"1991","journal-title":"Acta Orthop. Scand."},{"key":"B17","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0360-3016(94)90519-3","article-title":"Randomized trial comparing preoperative versus postoperative irradiation for prevention of heterotopic ossification following prosthetic total hip replacement: preliminary results","volume":"30","author":"Gregoritch","year":"1994","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"B18","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1177\/1120700020978194","article-title":"Diclofenac for prophylaxis of heterotopic ossification after hip arthroplasty: a systematic review","volume":"32","author":"Haffer","year":"2022","journal-title":"HIP Int."},{"key":"B19","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/s0883-5403(08)80097-6","article-title":"Single-dose radiation therapy for prevention of heterotopic ossification after total hip arthroplasty","volume":"5","author":"Healy","year":"1990","journal-title":"J. Arthroplasty"},{"key":"B20","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/s0883-5403(89)80033-6","article-title":"The prevention of heterotopic bone formation following total hip arthroplasty using 600 rad in a single dose","volume":"4","author":"Hedley","year":"1989","journal-title":"J. Arthroplasty"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1007\/s00590-024-03896-9","article-title":"Incidence of heterotopic ossification following total hip arthroplasty by approach: a systematic review","volume":"34","author":"Herzberg","year":"2024","journal-title":"Eur. J. Orthop. Surg. Traumatol. Orthop. Traumatol."},{"key":"B22","first-page":"233","article-title":"Postoperative, conventional fractionated radiotherapy for prevention of heterotopic ossification after total endoprosthesis of the hip joint","volume":"48","author":"Heyd","year":"1995","journal-title":"Rontgenpraxis Z. fur Radiol. Tech."},{"key":"B23","first-page":"270","article-title":"Preoperative radiotherapy for prevention of heterotopic ossifications after hip endoprosthesis","volume":"7","author":"Heyd","year":"1997","journal-title":"Aktuelle Radiol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3928\/0147-7447-19990201-09","article-title":"General short-term indomethacin prophylaxis to prevent heterotopic ossification in total hip arthroplasty","volume":"22","author":"Hofmann","year":"1999","journal-title":"Orthopedics"},{"key":"B25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12891-017-1391-x","article-title":"Influence of surgical approach on heterotopic ossification after total hip arthroplasty - is minimal invasive better? A case control study","volume":"18","author":"H\u00fcrlimann","year":"2017","journal-title":"BMC Musculoskelet. Disord."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e158996","DOI":"10.1172\/jci.insight.158996","article-title":"Contemporary perspectives on heterotopic ossification","volume":"7","author":"Hwang","year":"2022","journal-title":"JCI Insight"},{"key":"B27","doi-asserted-by":"publisher","first-page":"409","DOI":"10.5435\/00124635-200211000-00005","article-title":"Heterotopic ossification after hip and knee arthroplasty: risk factors, prevention, and treatment","volume":"10","author":"Iorio","year":"2002","journal-title":"J. Am. Acad. Orthop. Surg."},{"key":"B28","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s004020050261","article-title":"Prevention of periarticular heterotopic ossification after endoprosthetic hip joint replacement by means of diclofenac","volume":"117","author":"Jockheck","year":"1998","journal-title":"Archives Orthop. Trauma Surg."},{"key":"B29","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.arth.2024.08.055","article-title":"The use of tranexamic acid for primary prophylaxis of heterotopic ossification following total hip arthroplasty","volume":"40","author":"Johnson","year":"2025","journal-title":"J. Arthroplasty"},{"key":"B30","doi-asserted-by":"publisher","first-page":"234","DOI":"10.5371\/hp.2017.29.4.234","article-title":"Extensive surgical wound lavage reduces the incidence and severity of heterotopic ossification in primary total hip replacement: a study of 175 hip replacements","volume":"29","author":"Kantak","year":"2017","journal-title":"Hip Pelvis"},{"key":"B31","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1007\/s004020050414","article-title":"Prevention of heterotopic bone formation after total hip arthroplasty: a prospective randomised study comparing postoperative radiation therapy with indomethacin medication","volume":"119","author":"Kienapfel","year":"1999","journal-title":"Arch. Orthop. Trauma Surg."},{"key":"B32","doi-asserted-by":"publisher","first-page":"639","DOI":"10.3109\/17453679308994587","article-title":"Indomethacin for prevention of heterotopic ossification. A randomized controlled study in 41 hip arthroplasties","volume":"64","author":"Kjaersgaard-Andersen","year":"1993","journal-title":"Acta Orthop. Scand."},{"key":"B33","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1097\/00003086-198911000-00030","article-title":"Erythrocyte sedimentation rate and heterotopic bone formation after cemented total hip arthroplasty","volume":"248","author":"Kjaersgaard-Andersen","year":"1989","journal-title":"Clin. Orthop. Relat. Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1302\/0301-620x.79b4.0790596","article-title":"Prevention of heterotopic ossification after total hip replacement. A prospective, randomised study using acetylsalicylic acid, indomethacin and fractional or single-dose irradiation","volume":"79","author":"Knelles","year":"1997","journal-title":"J. Bone Jt. Surg. Br."},{"key":"B35","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s00066-003-1088-y","article-title":"Preoperative irradiation for prevention of heterotopic ossification following prosthetic total hip replacement: results of a prospective study in 462 hips","volume":"179","author":"Koelbl","year":"2003","journal-title":"Strahlenther. Onkol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s004020050386","article-title":"No effective prophylaxis of heterotopic ossification with short-term ibuprofen","volume":"119","author":"Koorevaar","year":"1999","journal-title":"Archives Orthop. Trauma Surg."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1016\/j.arth.2011.11.017","article-title":"Low rates of heterotopic ossification after resurfacing hip arthroplasty with use of prophylactic radiotherapy in select patients","volume":"27","author":"Kruser","year":"2012","journal-title":"J. Arthroplasty"},{"key":"B38","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/s0360-3016(98)00204-1","article-title":"Preoperative irradiation versus the use of nonsteroidal anti-inflammatory drugs for prevention of heterotopic ossification following total hip replacement: the results of a randomized trial","volume":"42","author":"K\u0308olbl","year":"1998","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"B39","doi-asserted-by":"publisher","first-page":"S312","DOI":"10.1016\/j.arth.2024.02.017","article-title":"Surgical treatment of severe heterotopic ossification after total hip arthroplasty over the last 25 years: a systematic review of the literature and a new case series","volume":"39","author":"Lachiewicz","year":"2024","journal-title":"J. Arthroplasty"},{"key":"B40","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.arth.2013.06.039","article-title":"Celecoxib and heterotopic bone formation after total hip arthroplasty","volume":"29","author":"Lavernia","year":"2014","journal-title":"J. Arthroplasty"},{"key":"B41","doi-asserted-by":"publisher","first-page":"3860142","DOI":"10.1155\/2019\/3860142","article-title":"Heterotopic ossification: a challenging complication of total hip arthroplasty: risk factors, diagnosis, prophylaxis, and treatment","volume":"2019","author":"\u0141\u0119gosz","year":"2019","journal-title":"Biomed. Res. Int."},{"key":"B42","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1148\/radiology.168.3.3136510","article-title":"Heterotopic bone formation after hip surgery: prevention with single-dose postoperative hip irradiation","volume":"168","author":"Lo","year":"1988","journal-title":"Radiology"},{"key":"B43","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1002\/sim.1201","article-title":"Network meta-analysis for indirect treatment comparisons","volume":"21","author":"Lumley","year":"2002","journal-title":"Statistics Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13018-018-0747-8","article-title":"Efficacy of naproxen prophylaxis for the prevention of heterotopic ossification after hip surgery: a meta-analysis","volume":"13","author":"Ma","year":"2018","journal-title":"J. Orthop. Surg. Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1517\/14656566.9.5.767","article-title":"Pharmacological treatment of heterotopic ossification following hip and acetabular surgery","volume":"9","author":"Macfarlane","year":"2008","journal-title":"Expert Opin. Pharmacother."},{"key":"B46","first-page":"766","article-title":"The use of radiotherapy in the prevention of heterotopic ossification in patients with total hip replacement","volume":"92","author":"Marziano","year":"1996","journal-title":"La Radiol. Med."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1080\/14656566.2022.2088280","article-title":"A comprehensive update on the pharmacological management of heterotopic ossification following hip arthroplasty: a level I evidenced based expert opinion","volume":"23","author":"Migliorini","year":"2022","journal-title":"Expert Opin. Pharmacother."},{"key":"B48","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/s00223-020-00763-7","article-title":"NSAIDs for prophylaxis for heterotopic ossification after total hip arthroplasty: a Bayesian network meta-analysis","volume":"108","author":"Migliorini","year":"2021","journal-title":"Calcif. Tissue Int."},{"key":"B49","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1016\/j.arth.2024.05.043","article-title":"Should we wait for bone-on-bone arthritis? Equivalent clinical outcomes in patients requiring advanced imaging before primary total hip arthroplasty","volume":"39","author":"Neitzke","year":"2024","journal-title":"J. Arthroplasty"},{"key":"B50","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s13018-021-02297-6","article-title":"Etoricoxib is safe and effective in preventing heterotopic ossification after primary total hip arthroplasty","volume":"16","author":"Oberberg","year":"2021","journal-title":"J. Orthop. Surg. Res."},{"key":"B51","doi-asserted-by":"publisher","first-page":"256","DOI":"10.5301\/hipint.5000109","article-title":"Effect of a selective COX-2 inhibitor, celecoxib, on heterotopic ossification after total hip arthroplasty: a case-controlled study","volume":"24","author":"Oni","year":"2014","journal-title":"HIP Int."},{"key":"B52","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1177\/1120700019842724","article-title":"Is prophylaxis for heterotopic ossification with radiation therapy after THR associated with early loosening or carcinogenesis?","volume":"30","author":"Pakos","year":"2020","journal-title":"HIP Int."},{"key":"B53","doi-asserted-by":"publisher","first-page":"e23530","DOI":"10.1097\/md.0000000000023530","article-title":"Hemiarthroplasty versus total hip arthroplasty for displaced femoral neck fracture in patients older than 80 years: a randomized trial protocol","volume":"99","author":"Peng","year":"2020","journal-title":"Medicine"},{"key":"B54","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3109\/17453679809117608","article-title":"Preventive effects of ibuprofen on periarticular heterotopic ossification after total hip arthroplasty. A randomized double-blind prospective study of treatment time","volume":"69","author":"Persson","year":"1998","journal-title":"Acta Orthop. Scand."},{"key":"B55","doi-asserted-by":"publisher","first-page":"101828","DOI":"10.1016\/j.bonr.2025.101828","article-title":"Heterotopic ossification (HO) prophylaxis in total hip arthroplasty (THA): a systematic review of level I and level II evidence since 2000","volume":"24","author":"Puga","year":"2025","journal-title":"Bone Rep."},{"key":"B56","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.arth.2007.12.004","article-title":"Heterotopic ossification after surface replacement arthroplasty and total hip arthroplasty: a randomized study","volume":"24","author":"Rama","year":"2009","journal-title":"J. arthroplasty"},{"key":"B57","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/BF00180205","article-title":"The suppression of heterotopic ossification after total hip arthroplasty","volume":"16","author":"Reis","year":"1992","journal-title":"Int. Orthop."},{"key":"B58","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/s0883-5403(03)00279-1","article-title":"Celecoxib versus indomethacin in the prevention of heterotopic ossification after total hip arthroplasty","volume":"19","author":"Roman\u00f2","year":"2004","journal-title":"J. Arthroplasty"},{"key":"B59","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1302\/0301-620X.89B2.17747","article-title":"Celecoxib versus ibuprofen in the prevention of heterotopic ossification following total hip replacement: a prospective randomised trial","volume":"89","author":"Saudan","year":"2007","journal-title":"J. Bone Jt. Surg. Br."},{"key":"B60","doi-asserted-by":"publisher","first-page":"20210","DOI":"10.1038\/s41598-023-47508-8","article-title":"Efficacy of ibuprofen and indomethacin as prophylaxis of heterotopic ossification: a comparative study","volume":"13","author":"Schneider","year":"2023","journal-title":"Sci. Rep."},{"key":"B61","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0167-8140(93)90270-i","article-title":"Prevention of heterotopic ossification (HO) after total hip replacement: randomized high versus low dose radiotherapy","volume":"26","author":"Seegenschmiedt","year":"1993","journal-title":"Radiotherapy Oncol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/0360-3016(94)90520-7","article-title":"Preoperative versus postoperative radiotherapy for prevention of heterotopic ossification (HO): first results of a randomized trial in high-risk patients","volume":"30","author":"Seegenschmiedt","year":"1994","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"B63","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/s0883-5403(98)90189-9","article-title":"The suppression of heterotopic ossifications: radiation versus NSAID therapy--a prospective study","volume":"13","author":"Sell","year":"1998","journal-title":"J. arthroplasty"},{"key":"B64","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1177\/1120700021991115","article-title":"Efficacy of NSAIDs versus radiotherapy for heterotopic ossification prophylaxis following total hip arthroplasty in high-risk patients: a systematic review and meta-analysis","volume":"32","author":"Shapira","year":"2021","journal-title":"HIP Int."},{"key":"B65","first-page":"89","article-title":"Ectopic ossification after hip arthroplasty","volume":"67","author":"Sl\u00e4tis","year":"1978","journal-title":"Ann. Chir. Gynaecol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1055\/s-0042-1748947","article-title":"Efficacy of ibuprofen after total hip arthroplasty to prevent heterotopic ossification: systematic review and meta-analysis","volume":"58","author":"Tariq","year":"2023","journal-title":"Rev. Bras. Ortop."},{"key":"B67","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/0883-5403(92)90033-m","article-title":"Indomethacin for prevention of heterotopic ossification after total hip arthroplasty","volume":"7","author":"T\u00f6z\u00fcn","year":"1992","journal-title":"J. Arthroplasty"},{"key":"B68","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1080\/17453670610013475","article-title":"Prophylaxis for heterotopic ossifcation after primary total hip arthroplasty: a cohort study between indomethacin and meloxicam","volume":"78","author":"van der Heide","year":"2007","journal-title":"ACTA Orthop."},{"key":"B69","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3109\/17453679809117609","article-title":"Preoperative irradiation for prophylaxis of ectopic ossification after hip arthroplasty. A randomized study in 62 hips","volume":"69","author":"van Leeuwen","year":"1998","journal-title":"Acta Orthop. Scand."},{"key":"B70","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/00003086-199912000-00029","article-title":"Naproxen in the prevention of heterotopic ossification after total hip replacement","volume":"369","author":"Vielpeau","year":"1999","journal-title":"Clin. Orthop. Relat. Res."},{"key":"B71","doi-asserted-by":"publisher","first-page":"419","DOI":"10.3109\/17453679108996636","article-title":"Heterotopic bone formation prevented by diclofenac. Prospective study of 100 hip arthroplasties","volume":"62","author":"Wahlstr\u00f6m","year":"1991","journal-title":"Acta Orthop. Scand."},{"key":"B72","doi-asserted-by":"publisher","first-page":"100822","DOI":"10.1016\/j.mtbio.2023.100822","article-title":"NIR-triggered photodynamic therapy of traumatic heterotopic ossification with a type II collagen-targeted photosensitizer","volume":"23","author":"Wang","year":"","journal-title":"Mater Today Bio"},{"key":"B73","doi-asserted-by":"publisher","first-page":"5587","DOI":"10.2147\/JIR.S477382","article-title":"Estrogen deficiency exacerbates traumatic heterotopic ossification in mice","volume":"17","author":"Wang","year":"2024","journal-title":"J. Inflamm. Res."},{"key":"B74","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jot.2023.06.004","article-title":"Sustained notch signaling inhibition with a gamma-secretase inhibitor prevents traumatic heterotopic ossification","volume":"42","author":"Wang","year":"","journal-title":"J. Orthop. Transl."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1090529","DOI":"10.3389\/fimmu.2022.1090529","article-title":"Differential expression profiles and functional prediction of circRNA in mice with traumatic heterotopic ossification","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Immunol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1039\/d2tb02157a","article-title":"Early diagnosis of heterotopic ossification with a NIR fluorescent probe by targeting type II collagen","volume":"11","author":"Wang","year":"","journal-title":"J. Mater Chem. B"},{"key":"B77","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s00264-015-3077-z","article-title":"Comparative clinical study of the prophylaxis of heterotopic ossifications after total hip arthroplasty using etoricoxib or diclofenac","volume":"40","author":"Winkler","year":"2016","journal-title":"Int. Orthop."},{"key":"B78","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1097\/00003086-199701000-00023","article-title":"Short term prophylaxis against heterotopic bone after cementless hip replacement","volume":"334","author":"Wurnig","year":"1997","journal-title":"Clin. Orthop. Relat. Res."},{"key":"B79","doi-asserted-by":"publisher","first-page":"e14607","DOI":"10.1097\/MD.0000000000014607","article-title":"A systematic review and meta-analysis of naproxen for prevention heterotopic ossification after hip surgery","volume":"98","author":"Zhang","year":"2019","journal-title":"Medicine"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1601349\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T10:01:03Z","timestamp":1747821663000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1601349\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,21]]},"references-count":79,"alternative-id":["10.3389\/fphar.2025.1601349"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1601349","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,21]]},"article-number":"1601349"}}